IDEXX Laboratories, Inc. recently announced the unanimous election of Sophie V. Vandebroek, PhD as a member of the Company's Board.
Dr. Vandebroek fills a vacancy on the Board for a Class II director, the term for which ends at the Company's 2014 annual meeting of stockholders. At that meeting, Dr. Vandebroek is expected to stand for re-election by stockholders as a Class II director with a three-year term expiring in 2017.
"I am very pleased to welcome Sophie to our Board," said Jonathan Ayers, Chairman of the Board and Chief Executive Officer of the Company. "IDEXX is entering a critical new phase in its evolution as a pet healthcare innovation company. IDEXX is unique in its ability to serve practicing veterinarians around the world with a broad range of integrated diagnostic and information technology-based products and services. To further build upon this opportunity, the Company will need to expand its skills and aptitudes. With Sophie's outstanding depth of knowledge and experience in technology and business processes as well as track record of innovation and managing balanced R&D portfolios for large global enterprises, she is ideally suited to help guide and advise the Board and the Company's management team."
Dr. Vandebroek has been an executive with Xerox Corp., an enterprise for business process and document management, since 2002. Most recently, Dr. Vandebroek has been serving as Xerox's Chief Technology Officer and Corporate VP, as well as President of the Xerox Innovation Group since 2006. She is responsible for overseeing Xerox's research centers in Europe, Asia, Canada and the U.S. as well as the Palo Alto Research Center. Prior to her current positions, from 2002 to 2005, Dr. Vandebroek was Chief Engineer of Xerox and VP of the Xerox Engineering Center.
Dr. Vandebroek is a Fellow of the Institute of Electrical & Electronics Engineers, a Fulbright Fellow, and a Fellow of the Belgian-American Educational Foundation. Dr. Vandebroek was inducted into the Women in Technology International Hall of Fame and elected into the Royal Flemish Academy for Arts & Sciences. Dr. Vandebroek holds more than a dozen U.S. patents and serves on the advisory council of the Dean of Engineering at MIT. Dr. Vandebroek has also served as a member of the Board of Analogic Corp., a designer and manufacturer of medical imaging and airport security systems, since 2008.
IDEXX Laboratories, Inc. is a company focusing on pet healthcare technology, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services.
((Comments on this story may be sent to email@example.com))